Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sulthan Al Rashid

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 28, 2026
Cardiovascular and Cerebrovascular Events Linked to Abuse and Misuse of Sympathomimetic Nasal Decongestants: A Narrative Review of Clinical EvidenceNaina Mohamed Pakkir Maideen, Sulthan Al Rashid
Current Drug Safety|April 6, 2026
Assessment of Iguratimod's Efficacy and Safety in Rheumatoid Arthritis: A Prospective, Open-Label StudyB Banupriya, Sulthan Al Rashid, Preetha Selva
Current Drug Safety|September 5, 2024
Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A EnzymesNaina Mohamed Pakkir Maideen, Sulthan Al Rashid
Cureus|September 2, 2024
Unveiling the Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Offering Protection of the Cardiovascular, Renal, and Neural Systems: An Updated Narrative ReviewDivya Rajagopal, Sulthan Al Rashid, Monisha Prasad, et al.
Indian Journal of Ophthalmology|March 12, 2026
Ocular complications associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Clinical evidence and insightsNaina Mohamed Pakkir Maideen, Sulthan Al Rashid, Rajkapoor Balasubramanian, et al.
Current Drug Research Reviews|August 28, 2025
Exploring the Therapeutic Potential of SGLT-2 Inhibitors in Managing Metabolic Syndrome: A Narrative ReviewSulthan Al Rashid, Monisha Prasad, Inamul Hasan Madar, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 5, 2026
Exploring the Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in Patients with Type 2 Diabetes: A Narrative ReviewSulthan Al Rashid, Arun Suriyan, Mohamed Bilal Azam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 28, 2026
Cardiovascular and Cerebrovascular Events Linked to Abuse and Misuse of Sympathomimetic Nasal Decongestants: A Narrative Review of Clinical EvidenceNaina Mohamed Pakkir Maideen, Sulthan Al Rashid
Current Drug Safety|April 6, 2026
Assessment of Iguratimod's Efficacy and Safety in Rheumatoid Arthritis: A Prospective, Open-Label StudyB Banupriya, Sulthan Al Rashid, Preetha Selva
Current Drug Safety|September 5, 2024
Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A EnzymesNaina Mohamed Pakkir Maideen, Sulthan Al Rashid
Cureus|September 2, 2024
Unveiling the Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Offering Protection of the Cardiovascular, Renal, and Neural Systems: An Updated Narrative ReviewDivya Rajagopal, Sulthan Al Rashid, Monisha Prasad, et al.
Indian Journal of Ophthalmology|March 12, 2026
Ocular complications associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Clinical evidence and insightsNaina Mohamed Pakkir Maideen, Sulthan Al Rashid, Rajkapoor Balasubramanian, et al.
Current Drug Research Reviews|August 28, 2025
Exploring the Therapeutic Potential of SGLT-2 Inhibitors in Managing Metabolic Syndrome: A Narrative ReviewSulthan Al Rashid, Monisha Prasad, Inamul Hasan Madar, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 5, 2026
Exploring the Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in Patients with Type 2 Diabetes: A Narrative ReviewSulthan Al Rashid, Arun Suriyan, Mohamed Bilal Azam, et al.
Pageof 1